{
    "Trade/Device Name(s)": [
        "Gmate VOICE Blood Glucose Monitoring System",
        "Gmate Control Solution",
        "Gmate Blood Glucose Test Strips"
    ],
    "Submitter Information": "Philosys Co Ltd",
    "510(k) Number": "K113636",
    "Predicate Device Reference 510(k) Number(s)": [
        "K002134"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA",
        "NBW",
        "JJX"
    ],
    "Summary Letter Date": "March 8, 2013",
    "Summary Letter Received Date": "February 15, 2013",
    "Submission Date": "February 14, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Quality Control Material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Gmate VOICE Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Glucose oxidase method",
        "Electrochemical detection"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Monitoring System",
        "Control Solution",
        "Test Strip"
    ],
    "Document Summary": "FDA 510(k) summary for Gmate VOICE Blood Glucose Monitoring System and associated control solution for quantitative blood glucose measurement using electrochemical detection.",
    "Indications for Use Summary": "For quantitative measurement of glucose in fresh capillary whole blood from various body sites by diabetic individuals at home to aid in diabetes management; not for diagnosis or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}